Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

heartbeam inc - BEAT

BEAT

Close Chg Chg %
0.40 -0.00 -1.21%

Closed Market

0.39

0.00 (1.21%)

Volume: 545.33K

Last Updated:

Oct 23, 2026, 4:00 PM EDT

Trade Now

Company Overview: heartbeam inc - BEAT

BEAT Key Data

Open

$0.40

 Day Range

0.39 - 0.40

52 Week Range

0.36 - 4.00

 Market Cap

$23.10M

Shares Outstanding

56.35M

 Public Float

46.27M

Beta

-0.77

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$0.51

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

20.28M

  

BEAT Performance

1 Week
 
 -9.79%
 
1 Month
 
 9.31%
 
3 Months
 
 -23.14%
 
1 Year
 
 -76.16%
 
5 Years
 
 N/A
 

BEAT Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 3
Full Ratings ➔

About heartbeam inc - BEAT

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.

BEAT At a Glance

HeartBeam, Inc.
2118 Walsh Avenue
Santa Clara, California 95050
Phone 1-408-899-4443 Revenue 0.00
Industry Medical Specialties Net Income -21,015,000.00
Sector Health Technology Employees 16
Fiscal Year-end 12 / 2026
View SEC Filings

BEAT Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio N/A
Price to Book Ratio 36.991
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -3.627
Enterprise Value to Sales N/A
Total Debt to Enterprise Value N/A

BEAT Efficiency

Revenue/Employee N/A
Income Per Employee -1,313,437.50
Receivables Turnover N/A
Total Asset Turnover N/A

BEAT Liquidity

Current Ratio 1.446
Quick Ratio 1.414
Cash Ratio 1.352

BEAT Profitability

Gross Margin N/A
Operating Margin N/A
Pretax Margin N/A
Net Margin N/A
Return on Assets -460.906
Return on Equity -987.315
Return on Total Capital -807.338
Return on Invested Capital -987.315

BEAT Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital N/A
Total Debt to Total Assets N/A
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital N/A
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Heartbeam Inc - BEAT

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
- - - -
-
Sales Growth
- - - -
-
Cost of Goods Sold (COGS) incl D&A
- - 7.00K 40.00K
-
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
- - 7.00K 40.00K
-
Depreciation
- - 7.00K 40.00K
-
Amortization of Intangibles
- - - -
-
COGS Growth
- - - +471.43%
-
Gross Income
- - (7.00K) (40.00K)
-
Gross Income Growth
- - - -471.43%
-
Gross Profit Margin
- - - -
-
2022 2023 2024 2025 5-year trend
SG&A Expense
13.03M 15.31M 19.88M 21.10M
Research & Development
5.68M 6.80M 11.05M 13.45M
Other SG&A
7.35M 8.52M 8.83M 7.65M
SGA Growth
+470.28% +17.52% +29.82% +6.13%
Other Operating Expense
- - - -
-
Unusual Expense
- - - (3.00K)
-
EBIT after Unusual Expense
(13.03M) (15.31M) (19.89M) (21.14M)
Non Operating Income/Expense
66.00K 675.00K 439.00K 124.00K
Non-Operating Interest Income
66.00K 675.00K 446.00K 122.00K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -100.00%
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
(12.96M) (14.64M) (19.45M) (21.02M)
Pretax Income Growth
-192.73% -12.94% -32.85% -8.06%
Pretax Margin
- - - -
-
Income Tax
- - - -
-
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(12.96M) (14.64M) (19.45M) (21.02M)
Minority Interest Expense
- - - -
-
Net Income
(12.96M) (14.64M) (19.45M) (21.02M)
Net Income Growth
-192.73% -12.94% -32.85% -8.06%
Net Margin Growth
- - - -
-
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(12.96M) (14.64M) (19.45M) (21.02M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(12.96M) (14.64M) (19.45M) (21.02M)
EPS (Basic)
-1.5868 -0.72 -0.7299 -0.6234
EPS (Basic) Growth
-179.86% +54.63% -1.38% +14.59%
Basic Shares Outstanding
8.17M 20.33M 26.65M 33.71M
EPS (Diluted)
-1.5868 -0.72 -0.7299 -0.6234
EPS (Diluted) Growth
-179.86% +54.63% -1.38% +14.59%
Diluted Shares Outstanding
8.17M 20.33M 26.65M 33.71M
EBITDA
(13.03M) (15.31M) (19.88M) (21.10M)
EBITDA Growth
-470.28% -17.52% -29.82% -6.13%
EBITDA Margin
- - - -
-

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 3.167
Number of Ratings 3 Current Quarters Estimate -0.087
FY Report Date 12 / 2026 Current Year's Estimate -0.383
Last Quarter’s Earnings -0.09 Median PE on CY Estimate N/A
Year Ago Earnings -0.62 Next Fiscal Year Estimate -0.287
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 2 3 3
Mean Estimate -0.09 -0.08 -0.38 -0.29
High Estimates -0.08 -0.07 -0.37 -0.24
Low Estimate -0.10 -0.08 -0.41 -0.34
Coefficient of Variance -13.32 -9.43 -6.02 -17.56

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 4
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Buy

Insider Actions for Heartbeam Inc - BEAT

Date Name Shares Transaction Value
Oct 12, 2026 Richard M. Ferrari Director 125,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Richard M. Ferrari Director 90,625 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Richard M. Ferrari Director 125,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Willem Pieter Elfrink Director 93,750 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Willem Pieter Elfrink Director 93,750 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 George A. de Urioste Director 93,750 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 George A. de Urioste Director 93,750 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Marga Ortigas-Wedekind Director 93,750 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Marga Ortigas-Wedekind Director 81,250 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Kenneth Nelson Director 93,750 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Kenneth Nelson Director 31,250 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Michael R. Jaff Director 93,750 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Michael R. Jaff Director 37,500 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Heartbeam Inc in the News